SVLSF IV, LLC

SVLSF IV, LLC has an estimated net worth of $132 Million. This is based on reported shares across multiple companies, which include ENTELLUS MEDICAL INC, NeurogesX Inc, KalVista Pharmaceuticals, Inc., OCULAR THERAPEUTIX, INC, Ophthotech Corp., and TRANSENTERIX INC..

2014 was SVLSF IV, LLC's most active year for acquiring shares with 6 total transactions. SVLSF IV, LLC's most active month to acquire stocks was the month of June. 2019 was SVLSF IV, LLC's most active year for disposing of shares, totalling 36 transactions. SVLSF IV, LLC's most active month to dispose stocks was the month of February. 2013 saw SVLSF IV, LLC paying a total of $4,619,916.00 for 17,333,034 shares, this is the most they've acquired in one year. In 2014 SVLSF IV, LLC cashed out on 5,075,933 shares for a total of $104,068,442.55, their largest year based on trade value.